Xu group is at the forefront of lipid nanoparticle (LNP) technology. Our primary focus is developing biodegradable lipids for precise nucleic acid delivery, advancing LNPs for immunotherapy and vaccine efficacy, and pioneering non-viral vectors for efficient gene editing. Our work emphasizes innovation in drug delivery systems to enhance therapeutic discoveries and genomic interventions.
We are excited to announce that our latest research, “Antitumour Vaccination via the Targeted Proteolysis of Antigens Isolated from Tumour Lysates,” has been published in Nature Biomedical Engineering! DOI: https://doi.org/10.1038/s41551-024-01285-5 In this study, Yu Zhao, Donghui Song, Zeyu Wang, Qingqing
Congratulations to Dr. Qiaobing Xu on his appointment as co-editor-in-chief, alongside Dr. Fabiana Quaglia from the University of Naples Federico II, of the journal WIREs Nanomedicine and Nanobiotechnology. This interdisciplinary review journal aims to advance the field of nanotechnology by
Faculty members Michael Hughes, left, and Qiaobing Xu, right, with Dean of Research Matthew Panzer. Photo: Lorin Polidora. Professor Qiaobing Xu and Michael Hughes, the Ann W. Lambertus and Peter Lambertus Assistant Professor, were awarded for outstanding scholarly accomplishment. Tufts
Happy graduation to Dr. Jennifer, Zeyu, Huiwen, Chutian, and Lihan. Professor Xu and the other group members wish you all the best in your future endeavors. Congratulations!
On May 11th, Professor Xu and the group members gathered at Flamming and Grill Buffet for a lunch together. As graduation approached, the atmosphere was tinged with a sense of farewell for some of the group members. Amidst the grills
Newly named NAI senior members. Top row from left: Cheryl London, Mohan Thanikachalam, and Joshua Kritzer. Bottom row from left: Qiaobing Xu, Charlie Mace, and Pamela Yelick. Photos: Alonso Nichols and Anna Miller. Photo collage: Momo Shinzawa Six Tufts faculty